CORPAK MedSystems, a portfolio company of Linden Capital Partners, has bought Maxter Catheters. No financial terms were disclosed. Based in Marseille, France, Maxter is a maker of disposable medical devices.
BUFFALO GROVE, IL–(Marketwired – Nov 17, 2014) – CORPAK MedSystems, Inc., a global leader in Enteral access technologies, announced today that it has acquired the business of Marseille, France based Maxter Catheters. The acquisition enhances CORPAK’s research, development, and manufacturing capabilities and enables CORPAK to better serve global markets.
Bernard Daurelle, the founder and CEO of Maxter Catheters said, “We are thrilled to gain broader market access for our leading medical products by leveraging CORPAK’s commercial success and global reach.”
According to Tom Kuhn, President/COO for CORPAK, “We are confident that Maxter’s talented employees will bring unique expertise and experience to CORPAK and that all stakeholders will benefit from the broader CORPAK ingenuity and strength.”
Frank J. McCaney, CEO of CORPAK added, “CORPAK is committed to providing the most comprehensive range of products for patients requiring enteral therapy. Maxter’s existing products will complement our offerings and adding Maxter’s skill in innovation and rapid development to our already impressive capabilities will enhance the growth of CORPAK and increase our value to our customers around the world.”
Among Maxter Catheter’s current products are the ENTRAL™ and ENTRAL-VAC™ range of enteral feeding and aspiration tubes, enteral syringes, adapters, and accessories.
CORPAK Medsystems, Inc. is a portfolio company of Linden Capital Partners.
About CORPAK MedSystems:
CORPAK MedSystems is a leading global medical device company focused on Enteral access technologies. With more than 30 years of experience and a strong record of innovation, CORPAK partners with customers and stakeholders to create clinical and economic solutions, enabling better patient outcomes.
About Linden Capital Partners:
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. Linden’s strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare.
About Maxter Catheters:
Established in 1996, Maxter Catheters is specialized in the development and production of disposable medical devices. Maxter Catheters offers a wide range of gastric feeding and aspiration tubes for adults, pediatrics, and neonates designed and manufactured using state-of-the-art technological equipment. Maxter also develops new products for the latest medical techniques.